QUEST DIAGNOSTICS INC
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 21, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Sep 8, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 28, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| Jul 24, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 24, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 24, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Jul 24, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 24, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Jul 13, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Apr 22, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 22, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Apr 22, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 22, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Apr 8, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Feb 12, 2026 | Mizuho | maintain | Outperform → Outperform | $235 | 52% |
| Feb 11, 2026 | Truist Securities | maintain | Hold → Hold | $220 | 54% |
| Feb 11, 2026 | UBS | maintain | Neutral → Neutral | $210 | 54% |
| Feb 11, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $220 | 58% |
| Feb 11, 2026 | Barclays | maintain | Overweight → Overweight | $225 | 53% |
| Feb 11, 2026 | Jefferies | maintain | Buy → Buy | $220 | 52% |
| Feb 10, 2026 | Citigroup | maintain | Neutral → Neutral | $215 | 54% |
| Oct 27, 2025 | Piper Sandler | maintain | Neutral → Neutral | $200 | 54% |
| Oct 22, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $195 | 53% |
| Oct 22, 2025 | Truist Securities | maintain | Hold → Hold | $205 | 54% |
| Oct 21, 2025 | Leerink Partners | maintain | Outperform → Outperform | $210 | 51% |
| Oct 21, 2025 | Jefferies | maintain | Buy → Buy | $215 | 52% |
| Oct 17, 2025 | UBS | maintain | Neutral → Neutral | $190 | 54% |
| Oct 17, 2025 | Mizuho | maintain | Outperform → Outperform | $210 | 52% |
| Oct 8, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $190 | 58% |
| Oct 2, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $190 | 53% |
| Aug 25, 2025 | Baird | downgrade | Outperform → Neutral | $194 | 55% |
| Jul 23, 2025 | UBS | maintain | Neutral → Neutral | $180 | 54% |
| Jul 23, 2025 | Truist Securities | maintain | Hold → Hold | $192 | 54% |
| Jul 23, 2025 | Deutsche Bank | maintain | Hold → Hold | $178 | 57% |
| Jul 22, 2025 | Jefferies | maintain | Buy → Buy | $200 | 52% |
| Jul 18, 2025 | UBS | maintain | Neutral → Neutral | $175 | 54% |
| May 6, 2025 | JP Morgan | maintain | Neutral → Neutral | $190 | 54% |
| Apr 28, 2025 | Piper Sandler | maintain | Neutral → Neutral | $200 | 54% |
| Apr 23, 2025 | Truist Securities | maintain | Hold → Hold | $190 | 54% |
| Apr 23, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $185 | 53% |
| Apr 23, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $180 | 58% |
| Apr 23, 2025 | Baird | maintain | Outperform → Outperform | $194 | 55% |
| Apr 9, 2025 | Mizuho | maintain | Outperform → Outperform | $189 | 52% |
| Apr 2, 2025 | Redburn Atlantic | initiate | — → Buy | $195 | 49% |
| Mar 20, 2025 | Baird | maintain | Outperform → Outperform | $191 | 55% |
| Mar 4, 2025 | Citigroup | downgrade | Buy → Neutral | $185 | 54% |
| Feb 4, 2025 | JP Morgan | maintain | Neutral → Neutral | $180 | 54% |
| Feb 3, 2025 | Mizuho | maintain | Outperform → Outperform | $178 | 52% |
| Feb 3, 2025 | UBS | maintain | Neutral → Neutral | $170 | 54% |
No cross-platform signals in the last 90 days